|
Real-time Estimate
Cboe BZX
20:39:45 02/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 147.90 USD | +1.15% |
|
+1.83% | +3.03% |
| 09-01 | Procter & Gamble Announces Limited-Edition Febreze X Dunkin? Scent Collection | CI |
| 08-31 | Wella Files for IPO | DJ |
Company Valuation: Procter & Gamble Company
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 344,995 | 357,647 | 389,234 | 373,532 | 341,466 | 339,598 | - | - |
| Change | - | 3.67% | 8.83% | -4.03% | -8.58% | -0.55% | - | - |
| Enterprise Value (EV) 1 | 369,274 | 384,008 | 412,212 | 398,484 | 365,662 | 364,022 | 362,908 | 361,153 |
| Change | - | 3.99% | 7.34% | -3.33% | -8.24% | -0.45% | -0.31% | -0.48% |
| P/E | 24.7x | 25.7x | 27.4x | 24.5x | 22.2x | 21.5x | 19.8x | 18.9x |
| PBR | 7.35x | 7.66x | 8.06x | 7.48x | 6.54x | 6.18x | 5.94x | 5.67x |
| PEG | - | 16.59x | 13.47x | 3.01x | 13.14x | 7.61x | 2.32x | 3.8x |
| Capitalization / Revenue | 4.3x | 4.36x | 4.63x | 4.43x | 3.92x | 3.83x | 3.71x | 3.59x |
| EV / Revenue | 4.61x | 4.68x | 4.91x | 4.73x | 4.2x | 4.1x | 3.97x | 3.82x |
| EV / EBITDA | 17.9x | 18.4x | 18x | 17.1x | 15.5x | 15x | 14.2x | 13.5x |
| EV / EBIT | 20.7x | 21.2x | 20.6x | 19.5x | 17.8x | 17.4x | 16.5x | 15.7x |
| EV / FCF | 27.2x | 27.9x | 24.9x | 27.3x | 24.1x | 23.5x | 22.1x | 20.8x |
| FCF Yield | 3.67% | 3.59% | 4.01% | 3.67% | 4.14% | 4.26% | 4.52% | 4.82% |
| Dividend per Share 2 | 3.523 | 3.681 | 3.829 | 4.076 | 4.259 | 4.396 | 4.592 | 4.806 |
| Rate of return | 2.45% | 2.43% | 2.32% | 2.56% | 2.9% | 3.01% | 3.14% | 3.29% |
| EPS 2 | 5.81 | 5.9 | 6.02 | 6.51 | 6.62 | 6.807 | 7.387 | 7.755 |
| Distribution rate | 60.6% | 62.4% | 63.6% | 62.6% | 64.3% | 64.6% | 62.2% | 62% |
| Net sales 1 | 80,187 | 82,006 | 84,039 | 84,284 | 87,032 | 88,777 | 91,461 | 94,504 |
| EBITDA 1 | 20,620 | 20,848 | 22,884 | 23,303 | 23,657 | 24,257 | 25,571 | 26,749 |
| EBIT 1 | 17,813 | 18,134 | 19,988 | 20,456 | 20,497 | 20,953 | 22,031 | 23,061 |
| Net income 1 | 14,742 | 14,653 | 14,879 | 15,974 | 16,046 | 16,383 | 17,571 | 18,247 |
| Net Debt 1 | 24,279 | 26,361 | 22,978 | 24,952 | 24,196 | 24,424 | 23,310 | 21,555 |
| Reference price 2 | 143.79 | 151.74 | 164.92 | 159.32 | 146.64 | 146.21 | 146.21 | 146.21 |
| Nbr of stocks (in thousands) | 2,399,297 | 2,356,969 | 2,360,135 | 2,344,542 | 2,328,599 | 2,322,672 | - | - |
| Announcement Date | 29/07/22 | 28/07/23 | 30/07/24 | 29/07/25 | 29/07/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.48x | 4.1x | 15.01x | 3.01% | 340B | |
| 18.97x | 2.8x | 12.34x | 3.4% | 140B | |
| 24.38x | 3.65x | 15.35x | 2.37% | 71.45B | |
| 41.37x | 6.66x | 28.92x | 2.23% | 49.39B | |
| 33.73x | 2.57x | 14.28x | 1.6% | 36.18B | |
| 19.72x | 2.76x | 11.52x | 4.5% | 36.01B | |
| 23.42x | 1.71x | 10.97x | 2.16% | 20.43B | |
| 20.41x | 1.31x | 8.52x | 1.29% | 19.57B | |
| 16.16x | 1.55x | 8.86x | 3.28% | 19.73B | |
| 38.78x | 5.47x | 26.81x | 1.85% | 9.76B | |
| Average | 25.84x | 3.26x | 15.26x | 2.57% | 74.22B | |
| Weighted average by Cap. | 23.23x | 3.65x | 14.97x | 2.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- PG Stock
- Valuation Procter & Gamble Company
Select your edition
All financial news and data tailored to specific country editions
